Standard BioTools Inc.
LAB
$0.67
$0.023.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -121.06% | 558.96% | 155.59% | -3.67% | -28.53% |
| Total Depreciation and Amortization | -9.59% | -73.36% | 231.00% | -20.35% | -4.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.55% | -3,164.88% | -50.36% | 7.28% | 4.90% |
| Change in Net Operating Assets | 147.99% | 46.37% | -6,666.88% | -56.23% | 106.90% |
| Cash from Operations | 77.87% | -3,815.71% | 94.64% | -7.42% | 31.75% |
| Capital Expenditure | 39.65% | -19.75% | 46.28% | 53.05% | 62.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -93.12% | -- | -- | -- | -- |
| Other Investing Activities | 94.03% | -2,168.14% | -30.53% | -119.72% | 49.36% |
| Cash from Investing | -92.46% | 2,476.74% | -20.34% | -124.29% | 88.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.85% | -89.54% | -- | -100.00% | -- |
| Repurchase of Common Stock | -118.64% | 6.35% | -12.50% | 44.00% | -334.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -245.00% | -106.45% | 653.57% | -203.70% | 334.78% |
| Foreign Exchange rate Adjustments | 155.65% | 215.00% | 50.74% | -125.76% | 120.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -97.06% | 1,759.79% | 70.17% | -477.58% | 150.39% |